Core Laboratories Analyst Ratings
Core Laboratories Analyst Ratings
核心实验室分析师评级
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/31/2023 | -19.92% | Piper Sandler | $19 → $21 | Maintains | Neutral |
| 06/30/2023 | -19.92% | Citigroup | $22 → $21 | Downgrades | Neutral → Sell |
| 05/01/2023 | -27.55% | Piper Sandler | $18 → $19 | Maintains | Neutral |
| 04/28/2023 | -4.67% | Stifel | $24 → $25 | Maintains | Hold |
| 04/18/2023 | -18.02% | B of A Securities | → $21.5 | Downgrades | Neutral → Underperform |
| 02/07/2023 | -0.86% | Citigroup | $21 → $26 | Maintains | Neutral |
| 01/09/2023 | — | B of A Securities | Upgrades | Underperform → Neutral | |
| 10/07/2022 | — | Citigroup | Upgrades | Sell → Neutral | |
| 09/26/2022 | -23.74% | Morgan Stanley | → $20 | Downgrades | Equal-Weight → Underweight |
| 08/01/2022 | -23.74% | Morgan Stanley | $22 → $20 | Maintains | Equal-Weight |
| 07/13/2022 | -16.11% | Morgan Stanley | $32 → $22 | Maintains | Equal-Weight |
| 05/02/2022 | 22.02% | Morgan Stanley | $35 → $32 | Maintains | Equal-Weight |
| 04/18/2022 | -18.78% | Piper Sandler | $19.5 → $21.3 | Downgrades | Neutral → Underweight |
| 04/11/2022 | 33.46% | Morgan Stanley | $30 → $35 | Maintains | Equal-Weight |
| 01/18/2022 | 14.39% | Morgan Stanley | $32 → $30 | Maintains | Equal-Weight |
| 12/07/2021 | 22.02% | Morgan Stanley | $34 → $32 | Maintains | Equal-Weight |
| 10/18/2021 | 22.02% | B of A Securities | $36 → $32 | Downgrades | Neutral → Underperform |
| 10/11/2021 | 29.65% | Morgan Stanley | $37 → $34 | Maintains | Equal-Weight |
| 08/03/2021 | 41.09% | Morgan Stanley | $40 → $37 | Maintains | Equal-Weight |
| 07/09/2021 | 52.53% | Morgan Stanley | → $40 | Downgrades | Overweight → Equal-Weight |
| 06/14/2021 | 37.27% | Citigroup | $30 → $36 | Downgrades | Neutral → Sell |
| 03/25/2021 | 44.9% | Morgan Stanley | $33 → $38 | Maintains | Overweight |
| 12/18/2020 | -31.36% | JP Morgan | → $18 | Downgrades | Neutral → Underweight |
| 11/10/2020 | — | Morgan Stanley | Upgrades | Equal-Weight → Overweight | |
| 10/26/2020 | -4.67% | Morgan Stanley | $24 → $25 | Maintains | Equal-Weight |
| 09/29/2020 | — | ABN Amro | Upgrades | Sell → Hold | |
| 07/27/2020 | -38.99% | Piper Sandler | $15 → $16 | Maintains | Neutral |
| 07/24/2020 | -16.11% | Stifel | $15 → $22 | Maintains | Hold |
| 07/16/2020 | -27.55% | Scotiabank | → $19 | Downgrades | Sector Outperform → Sector Perform |
| 07/08/2020 | -8.48% | Morgan Stanley | $18 → $24 | Maintains | Equal-Weight |
| 05/19/2020 | -31.36% | Morgan Stanley | $12 → $18 | Maintains | Equal-Weight |
| 04/24/2020 | -42.8% | Stifel | $14 → $15 | Maintains | Hold |
| 04/13/2020 | -50.43% | Scotiabank | $40 → $13 | Upgrades | Sector Perform → Sector Outperform |
| 04/07/2020 | -71.4% | Piper Sandler | $16.5 → $7.5 | Maintains | Neutral |
| 03/18/2020 | -46.62% | Stifel | $17 → $14 | Maintains | Hold |
| 03/17/2020 | -38.99% | JP Morgan | $39 → $16 | Maintains | Neutral |
| 03/16/2020 | -54.24% | Morgan Stanley | $45 → $12 | Maintains | Equal-Weight |
| 03/13/2020 | -58.06% | Citigroup | $40 → $11 | Maintains | Neutral |
| 03/10/2020 | -35.18% | Stifel | $40 → $17 | Maintains | Hold |
| 03/09/2020 | — | B of A Securities | Downgrades | Buy → Underperform | |
| 01/30/2020 | — | Johnson Rice | Reinstates | → Buy | |
| 01/14/2020 | 47.95% | Bernstein | → $38.8 | Initiates Coverage On | → Market Perform |
| 01/02/2020 | 52.53% | Stifel | $50 → $40 | Downgrades | Buy → Hold |
| 12/31/2019 | 48.71% | Cowen & Co. | $42 → $39 | Maintains | Market Perform |
| 12/10/2019 | 75.41% | Citigroup | $44 → $46 | Maintains | Neutral |
| 10/18/2019 | 67.78% | Citigroup | $51 → $44 | Maintains | Neutral |
| 10/07/2019 | 109.72% | Morgan Stanley | $65 → $55 | Maintains | Equal-Weight |
| 09/11/2019 | 94.47% | Citigroup | $54 → $51 | Maintains | Neutral |
| 07/12/2019 | 166.92% | Morgan Stanley | $75 → $70 | Maintains | Equal-Weight |
| 07/10/2019 | 140.23% | B of A Securities | → $63 | Upgrades | Neutral → Buy |
| 01/04/2019 | 151.67% | Citigroup | $76 → $66 | Maintains | Neutral |
| 12/19/2018 | 185.99% | Credit Suisse | $105 → $75 | Downgrades | Outperform → Neutral |
| 12/12/2018 | 201.24% | JP Morgan | $111 → $79 | Maintains | Neutral |
| 12/11/2018 | 201.24% | JP Morgan | $111 → $79 | Downgrades | Overweight → Neutral |
| 11/16/2018 | — | Guggenheim | Upgrades | Neutral → Buy | |
| 11/01/2018 | — | ABN Amro | Upgrades | Sell → Buy | |
| 10/29/2018 | 300.38% | Morgan Stanley | $115 → $105 | Maintains | Equal-Weight |
| 10/29/2018 | 319.45% | Stifel | $117 → $110 | Upgrades | Hold → Buy |
| 10/26/2018 | 300.38% | Credit Suisse | $122 → $105 | Maintains | Outperform |
| 10/11/2018 | 338.51% | Morgan Stanley | $125 → $115 | Maintains | Equal-Weight |
| 09/19/2018 | 376.64% | Morgan Stanley | → $125 | Initiates Coverage On | → Equal-Weight |
| 09/17/2018 | 361.39% | JP Morgan | $118 → $121 | Maintains | Overweight |
| 09/14/2018 | 342.33% | Citigroup | $117 → $116 | Maintains | Neutral |
| 09/11/2018 | 346.14% | Stifel | → $117 | Initiates Coverage On | → Hold |
| 09/04/2018 | — | Edward Jones | Initiates Coverage On | → Buy | |
| 08/14/2018 | — | Citigroup | Upgrades | Sell → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 07/31/2023 | -19.92% | 派珀·桑德勒 | $19→$21 | 维护 | 中性 |
| 2023/06/30 | -19.92% | 花旗集团 | $22→$21 | 评级下调 | 中性→销售 |
| 05/01/2023 | -27.55% | 派珀·桑德勒 | $18→$19 | 维护 | 中性 |
| 04/28/2023 | -4.67% | Stifel | $24→$25 | 维护 | 保持 |
| 04/18/2023 | -18.02% | B of A证券 | →$21.5 | 评级下调 | 中性→表现不佳 |
| 02/07/2023 | -0.86% | 花旗集团 | $21→$26 | 维护 | 中性 |
| 01/09/2023 | - | B of A证券 | 升级 | 表现不佳的→中性 | |
| 10/07/2022 | - | 花旗集团 | 升级 | 卖出→中性 | |
| 09/26/2022 | -23.74% | 摩根士丹利 | →$20 | 评级下调 | 等重→减码 |
| 08/01/2022 | -23.74% | 摩根士丹利 | $22→$20 | 维护 | 等重 |
| 07/13/2022 | -16.11% | 摩根士丹利 | $32→$22 | 维护 | 等重 |
| 05/02/2022 | 22.02% | 摩根士丹利 | $35→$32 | 维护 | 等重 |
| 04/18/2022 | -18.78% | 派珀·桑德勒 | $19.5→$21.3 | 评级下调 | 中性→减持 |
| 04/11/2022 | 33.46% | 摩根士丹利 | $30→$35 | 维护 | 等重 |
| 01/18/2022 | 14.39% | 摩根士丹利 | $32→$30 | 维护 | 等重 |
| 12/07/2021 | 22.02% | 摩根士丹利 | $34→$32 | 维护 | 等重 |
| 10/18/2021 | 22.02% | B of A证券 | $36→$32 | 评级下调 | 中性→表现不佳 |
| 10/11/2021 | 29.65% | 摩根士丹利 | $37→$34 | 维护 | 等重 |
| 08/03/2021 | 41.09% | 摩根士丹利 | $40→$37 | 维护 | 等重 |
| 07/09/2021 | 52.53% | 摩根士丹利 | →$40 | 评级下调 | 超重→等重 |
| 2021/06/14 | 37.27% | 花旗集团 | $30→$36 | 评级下调 | 中性→销售 |
| 03/25/2021 | 44.9% | 摩根士丹利 | $33→$38 | 维护 | 超重 |
| 12/18/2020 | -31.36% | 摩根大通 | →$18 | 评级下调 | 中性→减持 |
| 11/10/2020 | - | 摩根士丹利 | 升级 | 等重→超重 | |
| 10/26/2020 | -4.67% | 摩根士丹利 | $24→$25 | 维护 | 等重 |
| 09/29/2020 | - | 荷兰银行 | 升级 | 销售→Hold | |
| 07/27/2020 | -38.99% | 派珀·桑德勒 | $15→$16 | 维护 | 中性 |
| 07/24/2020 | -16.11% | Stifel | $15→$22 | 维护 | 保持 |
| 07/16/2020 | -27.55% | 加拿大丰业银行 | →$19 | 评级下调 | 行业表现优于→行业表现 |
| 07/08/2020 | -8.48% | 摩根士丹利 | $18→$24 | 维护 | 等重 |
| 2020/05/19 | -31.36% | 摩根士丹利 | $12→$18 | 维护 | 等重 |
| 04/24/2020 | -42.8% | Stifel | $14→$15 | 维护 | 保持 |
| 04/13/2020 | -50.43% | 加拿大丰业银行 | $40→$13 | 升级 | 行业表现优于→行业表现 |
| 04/07/2020 | -71.4% | 派珀·桑德勒 | $16.5→$7.5 | 维护 | 中性 |
| 03/18/2020 | -46.62% | Stifel | $17→$14 | 维护 | 保持 |
| 03/17/2020 | -38.99% | 摩根大通 | $39→$16 | 维护 | 中性 |
| 03/16/2020 | -54.24% | 摩根士丹利 | $45→$12 | 维护 | 等重 |
| 03/13/2020 | -58.06% | 花旗集团 | $40→$11 | 维护 | 中性 |
| 03/10/2020 | -35.18% | Stifel | $40→$17 | 维护 | 保持 |
| 03/09/2020 | - | B of A证券 | 评级下调 | 购买表现不佳的→ | |
| 1/30/2020 | - | 约翰逊大米 | 恢复 | →购买 | |
| 2020/01/14 | 47.95% | 伯恩斯坦 | →$38.8 | 开始承保 | →市场表现 |
| 1/02/2020 | 52.53% | Stifel | $50→$40 | 评级下调 | 购买→Hold |
| 2019年12月31日 | 48.71% | 考恩公司 | $42→$39 | 维护 | 市场表现 |
| 2019年12月10日 | 75.41% | 花旗集团 | $44→$46 | 维护 | 中性 |
| 2019年10月18日 | 67.78% | 花旗集团 | $51→$44 | 维护 | 中性 |
| 2019/07/10 | 109.72% | 摩根士丹利 | $65→$55 | 维护 | 等重 |
| 2019/11/09 | 94.47% | 花旗集团 | $54→$51 | 维护 | 中性 |
| 2019年07月12日 | 166.92% | 摩根士丹利 | $75→$70 | 维护 | 等重 |
| 2019年07月10日 | 140.23% | B of A证券 | →$63 | 升级 | 中性→购买 |
| 2019年04月01日 | 151.67% | 花旗集团 | $76→$66 | 维护 | 中性 |
| 2018年12月19日 | 185.99% | 瑞士信贷 | $105→$75 | 评级下调 | 跑赢→中性 |
| 2018年12月12日 | 201.24% | 摩根大通 | $111→$79 | 维护 | 中性 |
| 2018年12月11日 | 201.24% | 摩根大通 | $111→$79 | 评级下调 | 超重→中性 |
| 2018年11月16日 | - | 古根海姆 | 升级 | 中性→购买 | |
| 2018/11/01 | - | 荷兰银行 | 升级 | 卖出→买入 | |
| 2018年10月29日 | 300.38% | 摩根士丹利 | $115→$105 | 维护 | 等重 |
| 2018年10月29日 | 319.45% | Stifel | $117→$110 | 升级 | 持有→购买 |
| 2018年10月26日 | 300.38% | 瑞士信贷 | $122→$105 | 维护 | 跑赢大盘 |
| 2018年10月11日 | 338.51% | 摩根士丹利 | $125→$115 | 维护 | 等重 |
| 2018年09月19日 | 376.64% | 摩根士丹利 | →$125 | 开始承保 | →等重 |
| 2018年09月17日 | 361.39% | 摩根大通 | $118→$121 | 维护 | 超重 |
| 2018年09月14日 | 342.33% | 花旗集团 | $117→$116 | 维护 | 中性 |
| 2018年09月11日 | 346.14% | Stifel | →$117 | 开始承保 | →保留 |
| 2018/09/04 | - | 爱德华·琼斯 | 开始承保 | →购买 | |
| 2018年08月14日 | - | 花旗集团 | 升级 | 卖出→中性 |
What is the target price for Core Laboratories (CLB)?
核心实验室(CLB)的目标价格是多少？
The latest price target for Core Laboratories (NYSE: CLB) was reported by Piper Sandler on July 31, 2023. The analyst firm set a price target for $21.00 expecting CLB to fall to within 12 months (a possible -19.92% downside). 10 analyst firms have reported ratings in the last year.
派珀·桑德勒于2023年7月31日报道了核心实验室(纽约证券交易所代码：CLB)的最新目标价。这家分析公司将目标价定为21.00美元，预计CLB将在12个月内下跌(可能下跌19.92%)。去年有10家分析公司公布了评级。
What is the most recent analyst rating for Core Laboratories (CLB)?
核心实验室(CLB)的最新分析师评级是多少？
The latest analyst rating for Core Laboratories (NYSE: CLB) was provided by Piper Sandler, and Core Laboratories maintained their neutral rating.
核心实验室(纽约证券交易所代码：CLB)的最新分析师评级由Piper Sandler提供，核心实验室维持中性评级。
When is the next analyst rating going to be posted or updated for Core Laboratories (CLB)?
核心实验室(CLB)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Core Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Core Laboratories was filed on July 31, 2023 so you should expect the next rating to be made available sometime around July 31, 2024.
分析师在进行了广泛的研究后得出了股票评级，这些研究包括查阅公共财务报表，与核心实验室的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。核心实验室的上一次评级是在2023年7月31日提交的，所以你应该预计下一次评级将在2024年7月31日左右的某个时候公布。
Is the Analyst Rating Core Laboratories (CLB) correct?
分析师对核心实验室(CLB)的评级正确吗？
While ratings are subjective and will change, the latest Core Laboratories (CLB) rating was a maintained with a price target of $19.00 to $21.00. The current price Core Laboratories (CLB) is trading at is $26.23, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的核心实验室(CLB)评级维持不变，目标价在19.00美元至21.00美元之间。核心实验室(CLB)目前的交易价格为26.23美元，超出了分析师的预测范围。